Background: Fewer than half of individuals with peripheral artery disease (PAD) experience classic claudication, and the relationships between PAD typical or atypical symptom intensity, location, and description (classic or atypical) with ischemic changes have not previously been reported.
P eripheral artery disease (PAD) is a progressive atherosclerotic occlusive disease affecting more than 8 million Americans and over 200 million individuals worldwide; sharp rises are expected due to population aging (Allison et al., 2007; Fowkes et al., 2013; Ostchega, Paulose-Ram, Dillon, Gu, & Hughes, 2007) . PAD is an independent risk factor for cardiovascular events and mortality; therefore, early detection and treatment are crucial to potentially prevent heart attack, stroke, and death (Criqui & Aboyans, 2015; Criqui, Ninomiya, Wingard, Ji, & Fronek, 2008; Diehm et al., 2009; Leng et al., 1996) . In PAD, arterial blood flow to the lower extremities is reduced, leading to exertional skeletal muscle ischemia that results in significant discomfort-even while walking short distances (Falcone et al., 2003) . The discomfort typically commences shortly after walking begins and resolves only when the activity ceases. Classic claudication is the most commonly recognized symptom of PAD and is described as an aching, cramping, and painful or tired feeling in the calves (Rose, 1962) .
The presentation and progression of PAD symptoms vary and may differ based on disease severity, disease location, age, the presence of certain comorbid conditions, such as neuropathy, arthritis, and spinal stenosis (McDermott et al., 2001; Newman et al., 2001) , or other unidentified factors. It is suspected that there are age-and gender-specific PAD symptoms beyond those of classic claudication; however, any such symptoms remain unconfirmed since the relationship between symptom reporting (intensity, location, and description) and changes in lower extremity tissue oxygenation during exercise is unknown (Schorr & Treat-Jacobson, 2013; .
Although classic claudication is considered the hallmark symptom of PAD, only 7.5%-33% of individuals with PAD report classic claudication as being part of their symptom experience (Schorr & Treat-Jacobson, 2013) . Because many patients with PAD do not experience classic claudication, heavy reliance on this symptom for screening and detection can result in mis-or underdiagnosis of the disease; thus, significant cardiovascular comorbidities and the incidence of mortality may increase (Criqui, Fronek, Klauber, BarrettConnor, & Gabriel, 1985; McDermott, Mehta, & Greenland, 1999; . For example, an individual reporting symptoms that are inconsistent with classic claudication may not trigger provider suspicion of the presence of PAD; therefore, individuals may not receive the necessary diagnostic testing and subsequent treatment for this chronic, debilitating disease.
PAD symptom reporting generally includes a verbal report of symptoms to a healthcare provider and written completion of a PAD symptom questionnaire in a static condition (e.g., questions about symptoms are answered during an office visit rather than during exercise when ischemia is actively occurring). Because exercise increases oxygen demand, it can be used to provoke PAD symptoms, enabling symptom assessment using a numerical rating scale (NRS) to capture the onset and progression in symptom intensity. To date, researchers have collected data on symptom rating (Treat-Jacobson, Henly, Bronas, Leon, & Henly, 2011) and perceived exertion during graded treadmill exercise (Collins et al., 2012) -in some cases, simultaneously measuring changes in tissue saturation index (TSI; Miranda et al., 2012) . However, analyzing TSI changes in relationship to symptom intensity or perceived exertion data is lacking. To our knowledge, this study is the first of its kind to collect data on self-reported symptoms of ischemia during exercise and recovery and, subsequently, evaluate the relationship between changes in calf tissue oxygenation (using TSI) and self-reported symptom intensity during treadmill exercise and recovery. Data on symptom intensity, location, and descriptor enabled a preliminary differentiation of symptoms related to ischemia versus nonischemic symptoms during three phases: at rest, during exercise, and during recovery, based on a previously published conceptual model of symptom differentiation (Schorr & TreatJacobson, 2013) . For example, heel discomfort at a constant intensity during exercise or sustained quadriceps discomfort would be considered nonischemic symptoms because symptoms consistent with ischemia are progressive in nature and consistently relieved during recovery. This was a necessary first step toward the creation of a more comprehensive set of diagnostic PAD symptom descriptors, including atypical symptoms, as well as symptom descriptors manifesting comorbid conditions unrelated to PAD (i.e., symptom confounders; Schorr & Treat-Jacobson, 2013) . This preliminary work laid a foundation for work toward the long-term goal of developing and refining age-and gender-specific PAD screening tools to improve and increase lifesaving detection, diagnosis, and treatment.
Purpose
The purpose of this study was to (a) evaluate the relationship between PAD symptom intensity and changes in calf tissue ischemia during treadmill exercise and recovery and (b) explore symptom locations and descriptors atypical of PAD reported in the presence of calf tissue ischemia.
METHODS

Design
This was a descriptive, exploratory study that examined the symptoms experienced by individuals with PAD during treadmill exercise and recovery (active and static conditions). In addition to completing the treadmill testing, participants were interviewed about their symptom experiences (see Schorr, Peden-McAlpine, Treat-Jacobson, & Lindquist, 2015) . During treadmill testing, calf tissue oxygenation via near-infrared spectroscopy (NIRS) and patient report of symptom intensity were obtained simultaneously. All protocols were reviewed and approved by the institutional review board at the University of Minnesota.
Sample
Inclusion criteria were (a) an ankle-brachial index (ABI) ≤ 0.90 or a postexercise drop in ABI confirming PAD, (b) exerciselimiting claudication or ischemia-related symptoms, (c) deemed safe to exercise based on the results of a cardiac stress test within the last 12 months, (d) English-speaking, (e) aged 21 years or older, and (f ) able to provide informed consent. Individuals were excluded from participation if they had (a) uncontrolled hypertension (systolic blood pressure [BP] > 200 mm Hg and/or diastolic BP > 100 mm Hg), (b) a vascular procedure within the last three months, or (c) exercise capacity limited by health problems other than claudication, such as angina or extreme dyspnea on exertion.
All study participants were recruited from the Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking (EXERT) study, which used the same inclusion and exclusion criteria listed previously (Treat-Jacobson, Bronas, & Leon, 2009 ). This study examined the efficacy of two forms of supervised exercise, arm ergometry and treadmill walking, compared to usual care provided by a physician for the treatment of PAD. All past or current EXERT participants assigned to any of the three EXERT treatment groups were eligible for participation. Previous EXERT participants received a letter describing the ancillary study, and current participants received a verbal description of the ancillary study by EXERT study staff. All current EXERT participants who were approached agreed to be contacted for potential participation in this ancillary study. The figure in Supplemental Digital Content 1, http://links.lww.com/NRES/A249, provides the details of study recruitment and enrollment (N = 40). Ankle-brachial Index The ABI, the ratio of ankle to arm systolic BP, was used to confirm the presence of PAD and to determine disease severity at the time of study enrollment. Participants rested for 10 minutes in the supine position, relaxed, head and heels supported, in a room with comfortable temperature prior to using a BP cuff, a standard sphygmomanometer, and a Doppler probe to obtain bilateral arm and leg systolic pressures according to standard procedures (Aboyans et al., 2012; Grenon, Gagnon, & Hsiang, 2009 ). An ABI ≤ 0.90 or a postexercise drop in ABI is diagnostic of PAD (Aboyans et al., 2012) . ABI was treated as a categorical variable, using five categories of PAD severity: <0.50 (severe PAD), 0.50 to less than 0.70 (moderate PAD), 0.70-0.90 (mild PAD), 0.91-0.99 (borderline PAD), and >1.40 (noncompressible arteries indicating PAD).
Measures
Subjective Symptom Reporting Symptom data included the intensity rating, location, and descriptor for each symptom experienced by participants during exercise and recovery. Symptom intensity was measured at the onset of symptoms and throughout symptom progression using a 6-point NRS. A scale ranging from 0 = no discomfort, 1 = symptom onset, and 5 = maximum discomfort experienced. During recovery, a rating of 0 corresponded to complete cessation of symptoms. Participants were encouraged to report symptoms they thought were related to PAD, as well as those presumed to be unassociated with the disease.
Objective Measurement of Calf Tissue Oxygenation Calf tissue oxygenation was measured using NIRS. The Artinis Medical Systems B.V. PortaMon NIRS device provided baseline and continuous wave measurement of tissue oxygenation, reported as TSI and expressed as a percentage, in the exercising calf muscle to determine the degree of calf tissue ischemia during static and active conditions (i.e., recovery and exercise). The PortaMon NIRS generated near-infrared light at two wavelengths, 760 and 850 nm, from three light-emitting diodes (interoptode distances of 30, 35, and 40 mm between the receiver and each of the three diodes). NIRS has been shown to be an inexpensive, noninvasive, accurate, stable, and sensitive tool to study the interactions between oxygen delivery and utilization in human skeletal muscle (Wariar, Gaffke, Haller, & Bertocci, 2000) . Among individuals with PAD, NIRS has demonstrated moderate to high test-retest reliability (Miranda et al., 2010 (Miranda et al., , 2012 ; parameters measured with NIRS can establish PAD presence, severity, and response to treatment and correlate well with ABI (Ferrari, Mottola, & Quaresima, 2004; Manfredini et al., 2009; Vardi & Nini, 2008) .
Study Procedures
After participants provided informed consent and Health Insurance Portability and Accountability Act authorization, data were collected from each participant's medical record.
Treadmill Familiarization and Testing Treadmill familiarization was completed prior to exercise testing to ensure participant safety and adequate understanding of treadmill exercise testing procedures and to determine the appropriate speed and grade for individual exercise testing. The speed during treadmill familiarization began at 1.5 miles per hour (mph) at a 0% grade. Both speed and grade were adjusted as necessary to induce ischemia-related discomfort within 3 minutes of commencing treadmill walking. The starting speed and grade for treadmill testing was individualized and determined by the results of the treadmill familiarization. Speed and grade progression were also individualized to prevent high-functioning participants from stopping the test due to symptoms other than calf ischemia and to prevent provoking discomfort too early in more severely limited participants, which would have potentially condensed symptom reporting. The average starting speed and grade was 2 mph at a 0% grade, with an increase in grade to 2% at 2 minutes. Thereafter, grade was increased by 1% every 2 minutes, maintaining a speed of 2 mph. If participants continued walking, the speed was increased to 2.5 mph at 16 minutes.
Next, participants verified their medical records and provided demographic information. After resting quietly in a supine position for 10 minutes, the principal investigator obtained the ABI according to standard procedures (Grenon et al., 2009 ). The Polar heart rate (HR) monitor was placed around the participant's chest, and a baseline HR was obtained. The PortaMon NIRS was wrapped in clear cellophane and placed at the level of the largest circumference of the medial gastrocnemius muscle of the more symptomatic leg as reported by each study participant, regardless of disease severity based on the ABI. If participants reported equal symptom severity in both legs, the device was placed on the leg with the higher disease severity (i.e., lower ABI determined by confirmatory ABI). The PortaMon NIRS was covered with a black cloth, secured with Coban self-adherent wrap, and paired via Bluetooth with the dedicated study laptop computer.
Equilibration as well as baseline and continuous measurements were obtained following methods consistent with previous studies (Gardner et al., 2009; Hamaoka, McCully, Quaresima, Yamamoto, & Chance, 2007; Manfredini et al., 2009; and the principal investigator's previously conducted feasibility evaluation. Participants remained in a seated position while baseline HR, BP, and TSI values were obtained.
Safety Measures Exercise testing carries a small risk of heart attack (3.58 in 10,000) or death (0.50 in 10,000; Stuart & Ellestad, 1980) . Other potential risks to participants included exercise-related risks such as a change in BP, HR, and/or heart rhythm. The likelihood of potential risks was believed to be minimal. The following procedures were in place to decrease the potential risks described: pre-and postexercise BP, periodic BP during exercise, continuous HR using a PolarHR monitor strap (cutoff was 85% maximal HR based on stress test results), and pre-and postexercise blood glucose levels for any participant with a confirmed diagnosis of diabetes mellitus (Type 1 or Type 2).
Each treadmill test was started at the speed and grade determined during the treadmill familiarization. Participants were asked to describe the symptom experience by providing the symptom intensity using the NRS, symptom location, and a descriptor for each location (e.g., "1/5, left calf, ache"); thereafter, they were asked to report the progression of symptom intensity in whole integers on the NRS, until the maximum discomfort level was achieved (i.e., reported NRS score was 5/5). Symptom data were recorded on a paper data collection form, as well as audio-recorded for the purposes of data verification. After reaching an NRS rating of 5, the treadmill speed and grade were reduced slowly until the participant was able to safely stop walking on the treadmill. Participants were then assisted off of the treadmill and into a seated, resting position in a chair.
At the beginning of the recovery period, postexercise HR and BP were obtained. Data collection continued throughout recovery (i.e., symptom intensity, location, descriptor, and TSI values). Full recovery was reached when participants reported an NRS rating of 0 (no pain), and HR and BP returned to or fell below baseline values. Two additional exercise tests were performed during the same session, following the same procedures as the first treadmill test.
Statistical Analysis
Data were collected during the resting, exercise, and recovery phases of three consecutive treadmill tests with variable rest periods in between based on time to return to baseline values. Statistical analysis included descriptive statistics and multilevel modeling (R version 3.2.2).
Multilevel Model for Change Building a multilevel model allowed for an examination of the associations between selfreported symptom intensity and changes in TSI while accommodating within-subject clustering. Multilevel modeling characterized change within and between individuals over time (Singer & Willett, 2003) .
Data were organized in a person-level data set and structured hierarchically; repeated observations were nested within individuals. The outcome variable was TSI, expressed as a percentage and recorded continuously over time. TSI values that matched up with precise time points of each symptom rating during exercise and recovery were extracted and served as the outcome variable for all models. Individual-level predictors in both the exercise and recovery conditional growth models were baseline TSI, disease severity as measured by ABI, age, body mass index (BMI), gender, race, smoking status, diabetes, and neuropathy. Exercise time and exercise NRS ratings were included in the exercise model, whereas recovery time and recovery NRS ratings were included in the recovery model.
Multilevel modeling was divided into two phases: exercise and recovery. We accommodated intrasubject dependence by including per-subject random intercepts in the models. The estimation method was restricted maximum likelihood, which accommodates data missing at random. A likelihood ratio test determined that the random effects were necessary. There was no evidence to suggest that per-person slopes were appropriate. Individual growth curves during the exercise phase for a random subset of 12 study participants were examined, and a negative, linear relationship with varying intercepts was observed. Similarly, graphical analysis of the recovery data for another random subset of 12 study participants revealed a positive and linear relationship throughout recovery. Thus, a linear growth model was selected for both the exercise and recovery phases.
Two commonly used penalized likelihood criteria served as the foundation for model selection: Akaike's information criterion and Bayesian information criterion (BIC). Ideally, the final model would be favored by both criteria. However, BIC penalizes model complexity more heavily, so when the Akaike's information criterion and BIC disagreed, more consideration was given to the model favored by BIC to improve generalizability (Dziak, Coffman, Lanza, & Li, 2012; Raftery, 1995) . Other model selection criteria included residual analysis and ease of interpretability. For each phase, an unconditional means model, an unconditional growth model, and a conditional model including all 11 of the predictor variables were constructed. Nominal p-values of .05 were used.
Exploratory Analysis Individual graphs of TSI, symptom intensity, symptom locations, and symptom descriptors were explored. The primary purpose was to identify atypical symptom locations and descriptors that corresponded to changes in TSI indicative of the onset, progression, and resolution of ischemia. These graphs provide insights on how to proceed with future studies that are adequately powered to identify and compare patterns of calf tissue oxygenation in the presence of atypical versus classical PAD symptom reporting.
RESULTS
Sample
Characteristics of the 40 study participants appear in Table 1 . The average age of participants was 68 years (SD = 9.2), more than three quarters were male (88%), predominantly Caucasian (90%), and highly educated with most having completed some college or graduate school (78%). The average ABI indicated mild disease severity (M = 0.81, SD = 0.27). However, a mode ABI between 0.50 and 0.69 indicated that the largest percentage of participants had a moderate level of disease. Most of the participants were overweight or obese with a history of smoking. The most frequently diagnosed comorbidities were hypertension and hyperlipidemia; both are risk factors for the development of PAD. Most of the study participants were taking medications to control these conditions: nearly 83% (n = 33) were taking a cholesterol-lowering medication and an antiplatelet agent, and 70% (n = 28) were taking a cholesterol-lowering medication, antiplatelet agent, and antihypertensive medication.
Treadmill Exercise and Recovery
Exercise treadmill testing protocols were individualized since they were based on the results of individual treadmill familiarizations. However, most of the participants (n = 31, 78%) started walking at 2 mph and 0% grade. A summary of the treadmill speed and grade, as well as the performance during the exercise and recovery phases, is presented in the Table, Supplemental Digital Content 2, http://links.lww.com/NRES/ A250. On average, at each exercise test, participants walked 10 minutes 44 seconds (SD = 4 minutes 48 seconds). The average time to fully recover from exercise-induced ischemic symptoms between exercise tests was 6 minutes 4 seconds (SD = 4 minutes 10 seconds).
Ischemic Changes
Calf muscle tissue oxygenation, as measured by TSI values obtained via PortaMonNIRS, was recorded prior to the start of each test and throughout the exercise and recovery phases. A summary of TSI values obtained during all three phases is presented in the Table, Supplemental Digital Content 3, http://links.lww.com/NRES/A251. As expected, the average TSI of participants at baseline was higher than the average TSI during both the exercise and recovery phases. However, a surprising finding was that the average TSI at the point of self-reported full recovery (i.e., when NRS returned to 0) was actually higher than the baseline average.
There was minimal intraindividual variability between exercise TSI values for each of the three treadmill tests. Similarly, variability in intraindividual TSI values was minimal across Aboyans et al. (2012) .
d For categorization criteria, see Ardern, Janssen, Ross, and Katzmarzyk (2004) .
e Other includes Type 1 diabetes (n = 2, 5.0%), neuropathy (n = 8, 20%), rhythm disturbance (n = 7, 17.5%), cancer history (n = 4, 10.0%), depression (n = 4, 10.0%), metabolic syndrome (n = 3, 7.5%), anemia history (n = 2, 5.0%), rheumatoid arthritis (n = 2, 5.0%), and spinal stenosis (n = 1, 2.5%).
f Participants also used supplements: multivitamins (n = 20, 50.0%), fish oil (n = 12, 30.0%), and iron (n = 2, 5.0%).
each of the three recovery phases. These data suggest that individuals reached full recovery from ischemia between tests and performed consistently on all three treadmill tests (i.e., exercise duration), which eliminated the need to control for the sequence of exercise tests in multilevel modeling, simplifying the interpretation of the final model results.
Multilevel Modeling
Complete computer output for the unconditional means model, unconditional growth model, and a conditional model including all 11 of the predictor variables during exercise and recovery are available as a Exercise For the exercise data, 65% of the variation in TSI was attributable to individual differences (ρ = .65). Compared to the full model, the final model had a 14-point decrease in BIC, which provided very strong evidence to support choosing it as the final model (Dziak et al., 2012; Raftery, 1995) . The final model included exercise time, baseline TSI, NRS exercise rating, ABI category, and BMI category as covariates (Table 2) . Intercepts were allowed to vary by individual, but the slope was held constant. The final exercise model revealed a significant grand mean intercept and significant intercepts for each exercise rating (p < .001). Only three ABI categories were significantly predictive of TSI during exercise, suggesting that only moderate and severe PAD (ABI 0.50 −0.69 and ABI ≤0.49) or noncompressible arteries (ABI >1.40) influence TSI variability during exercise.
Recovery
In the unconditional means model, within-person variation (σ 2 ε = 89.41) was smaller than the between-person variation (σ 2 0 =170.70), and 66% of the variation in TSI was attributable to differences between individuals (ρ = .66). The final recovery model (Table 2 ) illustrated a significant grand mean intercept and significant intercepts for each recovery rating (p < .001). Other significant covariates included both interactions and ABI's indicative of noncompressible arteries (ABI >1.40) and the presence of moderate and severe disease (ABI 0.50-0.69 and ABI ≤0.49). Even though none of the BMI categories were significant, BMI was included in the final model for two reasons. First, it improved the overall fit of the final model. Second, BMI explained variation in the final model that was not being explained by the other covariates, as evidenced by a change in the p-value of the underweight category. Comparing the BIC of the full and final models, there was a 6-point decrease. The decrease in BIC provided Note. "-" indicates a referent category. N = 40. ABI = ankle-brachial index; BMI = body mass index; Est. = estimate; NRS = numerical rating scale; SE = standard error; TSI = tissue saturation index.
positive to strong evidence of choosing the final model over the full model.
Exploratory Analysis
Participants provided classic and atypical locations and descriptors during the onset, progression, and resolution of calf tissue ischemia. Some individuals described classic claudication (ache, cramp, pain, or tired in the calf ) at the onset of ischemia and at the point of maximum discomfort ( Figure 1A ). Others reported discomfort in the classic location (calf ) but used atypical words to describe ischemic changes, such as burn, tight, or pressure ( Figure 1B) . Perhaps the most interesting findings were the ischemic changes taking place while individuals reported discomfort in atypical locations using descriptors atypical of claudication. For example, a burning sensation in the foot reported at the onset of ischemia, and full symptom recovery reported when ischemia started to lessen, rather than when TSI values returned to baseline ( Figure 1C ). All of the symptom location and descriptor combinations provided by all 40 participants during 120 treadmill exercise tests is summarized in the (Gardner, Montgomery, & Afaq, 2007; Gardner et al., 2012) , only 69.2% (n = 83) of exercise tests were stopped due to discomfort in the calf-the classic location, with NRS equal to 5/5 in the calf-and classic descriptors were used only half the time to describe maximum calf discomfort (55.4%, n = 46). All of the symptom descriptors and locations provided during exercise appear in Table 3 . Tight was the most common atypical descriptor participants used to describe maximum calf discomfort (i.e., NRS 5/5 in the calf ); Table 4 provides a list of all the calf descriptors reported. Atypical symptom-limiting locations included the hip, hamstring, foot, and heel, with participants reporting classic and atypical descriptors at the point of maximum discomfort (NRS rating of 5 out of 5) during exercise. The frequencies for all of the other lower extremity locations and descriptors reported at maximum discomfort appear in the 
DISCUSSION
The most notable findings from this study are with regard to the relationship between symptom intensity and TSI values during exercise and recovery. All of the symptom intensity categories were significant for the exercise and recovery models. During exercise, the most severe decline in TSI was observed between the start of exercise and the onset of discomfort (i.e., NRS 1/5). For most individuals, TSI continued to decline slightly throughout the duration of exercise until the maximum discomfort was reached (i.e., NRS 5/5). The stamina exhibited by some individuals was in direct contrast to those FIGURE 1. Exemplars of changes in tissue saturation index (TSI) relative to classic claudication and atypical symptom reporting during exercise (E) and recovery (R). (A) Changes in TSI associated with ischemia during exercise and recovery of a participant exhibiting classic claudication in the calf, using a classic descriptor "ache." (B) Changes in TSI of an individual exhibiting classic claudication in the calf, but using an atypical descriptor "burn." (C) Changes in TSI of an individual exhibiting claudication in an atypical location, foot, and using an atypical descriptor "burn." who had to stop exercising as soon as TSI declined to a specific point. It is unknown whether there was a specific compensatory mechanism that allowed some individuals to continue exercising despite low TSI values or that enabled TSI values to increase above the minimum TSI obtained despite the progression of exercise intensity and duration.
During recovery, TSI values were at their lowest point when most participants were still experiencing maximum discomfort (i.e., NRS 5/5), and then TSI values steadily increased until full recovery was achieved (i.e., NRS 0/5). It has yet to be determined whether some individuals recover more quickly than others based on specific characteristics, such as gender or age, and why some individuals report a full recovery as soon as TSI peaks whereas others don't report a full recovery until sometime after the peak TSI has been reached and, in some cases, has declined. On average, TSI values were at the highest in the immediate postexercise period, indicating a postexercise increase in calf tissue oxygenation. This finding supports the positive effects observed when individuals with PAD participate in exercise therapy and achieve improvements in walking duration and/or distance.
In both the exercise and recovery models, age was a nonsignificant predictor of TSI. These findings are consistent with existing literature supporting that age in healthy individuals has no effect on tissue saturation values (Miranda et al., 2010) . Gender was also a nonsignificant predictor of TSI. Overall, male participants walked longer, but they exhibited lower TSI values. This directly contrasts the tissue saturation patterns identified in healthy subjects based on gender in which women had a 15% lower baseline TSI compared to men, with women maintaining lower values throughout exercise compared to men (Miranda et al., 2010) . However, in the Miranda et al. (2010) study, calf skinfold was 107% higher in women compared to men, and calf skin temperature of women was 3% lower. Adipose tissue thickness has been identified as a factor that influences oxygenation values (Van Beekvelt, Borghuis, , whereas the role of skin temperature is less understood. Gender may also influence PAD symptom location and descriptor reporting, with women reporting different symptoms since symptom definitions were based on male experiences and established at a time when ischemic atherosclerotic diseases were thought to primarily affect men.
During exercise, the most severe decline in TSI was observed between the start of exercise and the onset of discomfort.
Limitations
The PortaMon NIRS could not account for factors such as collaterals, cardiac function, inotropic and chronotropic response to therapeutic agents, vessel wall stiffness, and the presence of comorbid conditions that could have influenced calf tissue oxygenation during exercise (Manfredini et al., 2009 ). In addition, calf adipose tissue thickness and skin temperature were not measured in this study. Significant variations in either measure could have influenced oxygenations values. Individualized testing protocols were used to guide individuals through symptom progression while attempting to avoid stopping exercise for any other reasons (e.g., shortness of breath or overall fatigue). But the lack of a standardized exercise testing protocol may limit the comparison of study findings with future research studies. The sample in this study was small and relatively homogenous and recruited from a single-parent study in one geographical location. The lack of heterogeneity could have impacted the ability to construct stronger, more accurate models, which limits generalizability of the study findings to other individuals with PAD. However, the primary purpose of this study was to summarize the data of the study sample, gain an initial understanding of the relationship between symptom intensity and calf tissue oxygenation during exercise and recovery, and identify similarities and differences in symptom reporting, including atypical locations and descriptors. Future research collecting data from a larger number of individuals in a variety of geographical locations with more diverse backgrounds and a spectrum of disease severity will strengthen generalizability of study findings.
Conclusions
Participants with PAD provided classic and atypical symptom locations and descriptors during the onset, progression, and resolution of calf tissue ischemia during and after treadmill testing. Perception of maximum discomfort frequently occurred after the TSI nadir. Similarly, most reports of full symptom recovery occurred prior to complete resolution of ischemia. The results of this research are foundational for future studies to determine patterns of calf tissue oxygenation, its relationship to symptom intensity, location and description, and potential changes with therapeutic interventions. Further research is necessary to provide more information about the characteristics of individuals reporting atypical symptoms and to explore mechanisms that could explain the objective-subjective mismatch of all individuals with PAD-which would help better understand the full range of ischemic symptoms associated with PAD.
